GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CardioComm Solutions Inc (OTCPK:EKGGF) » Definitions » EV-to-EBITDA

CardioComm Solutions (CardioComm Solutions) EV-to-EBITDA : -231.17 (As of May. 12, 2024)


View and export this data going back to . Start your Free Trial

What is CardioComm Solutions EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CardioComm Solutions's enterprise value is $1.39 Mil. CardioComm Solutions's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.01 Mil. Therefore, CardioComm Solutions's EV-to-EBITDA for today is -231.17.

The historical rank and industry rank for CardioComm Solutions's EV-to-EBITDA or its related term are showing as below:

EKGGF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -756.72   Med: -6.68   Max: 598.42
Current: -272

During the past 13 years, the highest EV-to-EBITDA of CardioComm Solutions was 598.42. The lowest was -756.72. And the median was -6.68.

EKGGF's EV-to-EBITDA is ranked worse than
100% of 462 companies
in the Healthcare Providers & Services industry
Industry Median: 13.065 vs EKGGF: -272.00

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-12), CardioComm Solutions's stock price is $0.0038. CardioComm Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.000. Therefore, CardioComm Solutions's PE Ratio for today is N/A.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


CardioComm Solutions EV-to-EBITDA Historical Data

The historical data trend for CardioComm Solutions's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioComm Solutions EV-to-EBITDA Chart

CardioComm Solutions Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.75 -6.24 398.30 82.04 82.90

CardioComm Solutions Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.73 82.90 -653.12 -25.52 -271.95

Competitive Comparison of CardioComm Solutions's EV-to-EBITDA

For the Health Information Services subindustry, CardioComm Solutions's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioComm Solutions's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CardioComm Solutions's EV-to-EBITDA falls into.



CardioComm Solutions EV-to-EBITDA Calculation

CardioComm Solutions's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1.387/-0.006
=-231.17

CardioComm Solutions's current Enterprise Value is $1.39 Mil.
CardioComm Solutions's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CardioComm Solutions  (OTCPK:EKGGF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CardioComm Solutions's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0038/0.000
=N/A

CardioComm Solutions's share price for today is $0.0038.
CardioComm Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


CardioComm Solutions EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CardioComm Solutions's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioComm Solutions (CardioComm Solutions) Business Description

Traded in Other Exchanges
Address
18 Wynford Drive, Suite 305, North York, ON, CAN, M3C 3S2
CardioComm Solutions Inc develops advanced software, hardware and core laboratory reading services related to the electrocardiogram ("ECG") and ambulatory arrhythmia monitoring systems for medical and consumer markets. It engages in the provision of management software solutions. It specializes in software engineering of computer-based electrocardiogram management and reporting software. The company's products include software, Gems Win, Global ECG Management System, GlobalCardio 12 lead; hardware, include handheld ECG monitor; Asp Services, include ECG management service and smart monitoring; software modules, consists of Win Air, Auto attendant, HL7 interface and EMR integration; and other products, include ECG viewer SDK and QRS 12 lead universal.